Mujenda Florence H, Duarte Adriana M, Reilly Erin K, Strichartz Gary R
Pain Research Center, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Pain. 2007 Dec 15;133(1-3):161-73. doi: 10.1016/j.pain.2007.03.021. Epub 2007 Apr 27.
The contribution of endothelin-1 (ET-1), acting via endothelin-A receptors (ET(A)), on post-incisional pain was examined in a rat model of incision through the hairy skin of the lumbar dorsum. Post-incisional mechanical hyperesthesia was evaluated by cutaneous trunci muscle reflexes (CTMR) of subcutaneous muscles responding to stimulation with von Frey filaments near the wound (primary responses) and at a distance, especially on the contralateral dorsum (secondary responses, involving spinal circuits). The role of ET(A) was determined by pre-incisional, subcutaneous injection of the selective receptor antagonist BQ-123 at the incision site, 15 min or 24h before surgery. Control incisions showed both primary tactile allodynia and hyperalgesia, and a weaker secondary hyperesthesia, peaking 3-4h after surgery and lasting at least 24h. Primary allodynia, but not hyperalgesia, was dose-dependently suppressed by 15 min pre-incisional BQ-123. In contrast, both secondary allodynia and hyperalgesia were inhibited by local BQ-123. The suppression of primary allodynia by local antagonist disappeared in 24h, but that of secondary hyperesthesia remained strong for at least 24h. Systemically delivered BQ-123 was without effect on any post-incisional hyperesthesia, and if the antagonist was locally injected 24h before surgery there was no difference on hyperesthesia compared to vehicle injected at that time. We conclude that ET-1, released from skin by incision, activates nociceptors to cause primary allodynia and to sensitize spinal circuits through central sensitization. Blockade of ET(A) in the immediate peri-operative period prevents the later development of central sensitization.
通过对大鼠腰背部有毛皮肤进行切口的模型,研究了内皮素-1(ET-1)通过内皮素-A受体(ET(A))对切口后疼痛的作用。通过对伤口附近(主要反应)和远处,特别是对侧背部(次要反应,涉及脊髓回路)的皮下肌肉进行皮肌反射(CTMR)来评估切口后机械性感觉过敏,该反射由von Frey细丝刺激皮下肌肉引起。ET(A)的作用通过在手术前15分钟或24小时在切口部位进行术前皮下注射选择性受体拮抗剂BQ-123来确定。对照切口显示出原发性触觉异常性疼痛和痛觉过敏,以及较弱的继发性感觉过敏,在手术后3-4小时达到峰值并持续至少24小时。术前15分钟的BQ-123剂量依赖性地抑制原发性异常性疼痛,但不抑制痛觉过敏。相比之下,局部注射BQ-123可抑制继发性异常性疼痛和痛觉过敏。局部拮抗剂对原发性异常性疼痛的抑制作用在24小时内消失,但对继发性感觉过敏的抑制作用至少持续24小时。全身给药的BQ-123对任何切口后感觉过敏均无影响,并且如果在手术前24小时局部注射拮抗剂,则与当时注射赋形剂相比,感觉过敏没有差异。我们得出结论,切口从皮肤释放的ET-1激活伤害感受器,导致原发性异常性疼痛,并通过中枢敏化使脊髓回路敏感化。围手术期立即阻断ET(A)可防止中枢敏化的后期发展。